NIH Study Links Abnormal Prenatal DNA Tests to Cancer Detection
NIH researchers found undetected cancers in nearly half of pregnant people with abnormal prenatal cfDNA test results.
Read MorePosted by Andy Lundin | Dec 4, 2024 | Cancer, Prenatal Testing |
NIH researchers found undetected cancers in nearly half of pregnant people with abnormal prenatal cfDNA test results.
Read MorePosted by Andy Lundin | Dec 3, 2024 | Lung Cancer, Molecular Diagnostics |
Studies validated Biofidelity’s Aspyre Lung diagnostic tech, showcasing its ability to offer genomic profiling for actionable NSCLC variants.
Read MorePosted by Andy Lundin | Dec 3, 2024 | Cancer, Company News, Molecular Diagnostics |
OncoHost’s CLIA-certified proteomics lab received CAP accreditation, emphasizing its commitment to precision-focused diagnostics for cancer.
Read MorePosted by Chris Wolski | Nov 28, 2024 | Breast |
A researcher’s new mouse model for studying breast cancer could enhance understanding of cancer metastasis and its spread to organs.
Read MorePosted by Andy Lundin | Nov 21, 2024 | Lung Cancer, Molecular Diagnostics |
Biofidelity’s test delivers comprehensive genomic profiling for NSCLC patients from tissue or liquid biopsy samples within two days.
Read More